Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Mostrar otras versiones (1)

The SARS-CoV-2 pandemic has unprecedented implications for public health, social life, and the world economy. Because approved drugs and vaccines are limited or not available, new options for COVID-19 treatment and prevention are in high demand. To identify SARS-CoV-2-neutralizing antibodies, we ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreer, Christoph, Zehner, Matthias, Weber, Timm, Ercanoglu, Meryem S., Gieselmann, Lutz, Rohde, Cornelius, Halwe, Sandro, Korenkov, Michael, Schommers, Philipp, Vanshylla, Kanika, Di Cristanziano, Veronica, Janicki, Hanna, Brinker, Reinhild, Ashurov, Artem, Krähling, Verena, Kupke, Alexandra, Cohen-Dvashi, Hadas, Koch, Manuel, Eckert, Jan Mathis, Lederer, Simone, Pfeifer, Nico, Wolf, Timo, Vehreschild, Maria J.G.T., Wendtner, Clemens, Diskin, Ron, Gruell, Henning, Becker, Stephan, Klein, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355337/
https://www.ncbi.nlm.nih.gov/pubmed/32673567
http://dx.doi.org/10.1016/j.cell.2020.06.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355337/
https://www.ncbi.nlm.nih.gov/pubmed/32673567
http://dx.doi.org/10.1016/j.cell.2020.06.044

Ejemplares similares